共 52 条
[1]
Amin S(1999)Evaluating the health of the nation outcome scales: reliability and validity in a three-year follow-up of first-onset psychosis Br J Psychiatry 174 399-403
[2]
Barnes T(1989)A rating scale for drug-induced akathisia Br J Psychiatry 154 672-676
[3]
Chaudhry HR(2003)Quality of life and clinical outcomes for Asian outpatients with schizophrenia: a double-blind randomized comparison of olanzapine and haloperidol J Eur College Neuropsychopharm 13 S309-1376
[4]
Kongsakon R(2000)Atypical antipsychotics in the treatment of schizophrenia: systemic overview and meta-regression analysis BMJ 321 1371-288
[5]
Geddes J(1985)Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations Br J Psychiatry 147 283-88
[6]
Gerlach J(2003)World Health Organization Quality of Life Assessment; Brief Version in Bahasa Malaysia Malaysia Med J 58 79-30
[7]
Behnke K(1984)Clinical evaluation of sulpiride in schizophrenic patients—a double-blind comparison with chlorpromazine. Sulpiride in schizophrenic Acta Psychiatr Scand 69 7-1087
[8]
Heltberg J(2006)Randomized controlled trial of the effect on quality of life of second- vs. first- generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1) Arch Gen Psychiatry 63 1079-59
[9]
Munk-Anderson E(2000)Sex differences in the quality of life of people with schizophrenia Schizophr Res 41 58-38
[10]
Nielsen H(2000)Sex differences in schizophrenia,a review of the literature Acta Psychiatr Scand 101 3-1404